Forgot your password?

Forgot your username?

DATABASE UPDATES
  • DATATRAK International     United States  |  Global eClinical solutions for the clinical trials industry
  • Fibrocell Science      |  Develops personalized cell therapies for aesthetic, medical, and scientific...
  • Rubigo Therapeutics     United States  |  Delivery of skin cancer treatment Imiquimod through improved delivery...
  • Gynesonics    Redwood City, CA 94063  |  Gynesonics, Inc is a medical device company committed to...
  • NanoViricides, Inc.    West Haven, CT  |  Anti-viral drugs to fight HIV, influenza, and other infections
  • Nanobiotix     France  |  Non-invasive nanoparticle-based cancer therapy
  • Rib-X Pharmaceuticals      |  New antibiotics for Serious Drug Resistant Infections
NEWS
BREAKING NEWS: Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer
January 26 2012
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies.


S.E.A. Medical Secures $3 Million in Series B Financing from JK&B Capital
January 26 2012
Healthtech company makes strides towards developing medical devices designed to catch life-threatening IV drug errors before they harm patients


Provectus Receives Guidance From FDA On Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma
January 25 2012
Dr. Craig Dees talks candidly in a live audio interview about the company’s developments.


This Week In Diagnostics
January 24 2012
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.


Partners & Sponsors